Concepedia

Marianna Bitiņa

MB

5

Publications

960

Citations

5

H-Index

2005

Active since

Affiliations

Riga Stradiņš University(Current)

Heidelberg University

International Hereditary Cancer Center

Pomeranian Medical University

University Hospital Heidelberg

Marianna Bitiņa is an author at Riga Stradiņš University specializing in cancer therapeutics, clinical trials, and medicine.

Top concepts

MedicineOncologyCancer TherapyClinical TrialsHealthPathologyLung CancerPharmacologyBreast CancerCancer Research

Publications per year

2005–2020

5

Publications

5

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 55 citations

Antifibrotic Therapy, Fortis-m Trial, Medicine +9

Genotype-phenotype correlations among BRCA14153delA and 5382insC mutation carriers from Latvia

G. Plakhins, Arvīds Irmejs, Andris Gardovskis et al. · BMC Medical Genetics · 2011 · 20 citations · Full text

Pilot Study on Low Penetrance Breast and Colorectal Cancer Predisposition Markers in Latvia

Arvīds Irmejs, Edvīns Miklaševičs, Viktors Boroschenko et al. · Hereditary Cancer in Clinical Practice · 2006 · 19 citations · Full text

Clinical, Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in Latvia

Andris Gardovskis, Arvīds Irmejs, Edvīns Miklaševičs et al. · Hereditary Cancer in Clinical Practice · 2005 · 12 citations · Full text

Rows per page

1–5 of 5